World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
73
Citations
19094
World Ranking
2140
National Ranking
189

Overview

Robin J. Shattock is a researcher affiliated with Imperial College London in the United Kingdom. Their work spans medicine, biochemistry, genetics, molecular biology, immunology, microbiology, and infectious diseases. Key subfields include molecular biology, immunology, virology, and epidemiology.

The scientist's research primarily focuses on several main topics: SARS-CoV-2 and COVID-19 research, RNA interference and gene delivery, HIV research and treatment, advanced biosensing and bioanalysis techniques, immunotherapy and immune responses, animal virus infections studies, and SARS-CoV-2 detection and testing.

Shattock has published extensively in a variety of scientific venues. Frequent publication outlets include bioRxiv (Cold Spring Harbor Laboratory), Vaccines, npj Vaccines, Frontiers in Immunology, and Molecular Therapy - Nucleic Acids.

Collaborations have been a significant aspect of Shattock's scientific output. Frequent co-authors include Paul F. McKay, Anna K. Blakney, Karnyart Samnuan, Hannah M. Cheeseman, and Kai Hu.

Notable recent papers illustrate the research scope and areas of focus:

  • "Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice" (2020, Nature Communications)
  • "Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey" (2020, Thorax)
  • "Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial" (2022, EClinicalMedicine)
  • "Big Is Beautiful: Enhanced saRNA Delivery and Immunogenicity by a Higher Molecular Weight, Bioreducible, Cationic Polymer" (2020, ACS Nano)
  • "Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand" (2020, Vaccines)

Best Publications

  • In vitro and in vivo: the story of nonoxynol 9.

    Sharon L Hillier;Thomas Moench;Robin Shattock;Roberta Black

  • Inhibiting sexual transmission of HIV-1 infection

    Robin J. Shattock;John P. Moore

  • Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120

    Ronald S. Veazey;Robin J. Shattock;Melissa Pope;J. Christian Kirijan

  • Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice.

    Paul F. McKay;Kai Hu;Anna K. Blakney;Karnyart Samnuan

  • Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides.

    Peter Greenhead;Peter Hayes;Patricia S. Watts;Ken G. Laing

  • Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of their Replication Capacity in CD4 T-Lymphocytes and Monocyte-derived Macrophages

    Christina Ochsenbauer;Tara G. Edmonds;Haitao Ding;Brandon F. Keele

  • Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.

    Ronald S. Veazey;Per Johan Klasse;Susan M. Schader;Qinxue Hu

  • Target cells in vaginal HIV transmission.

    Christopher J. Miller;Robin J. Shattock

  • Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component

    Barry R. O'Keefe;Fakhrieh Vojdani;Viviana Buffa;Robin J. Shattock

  • Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved?

    Leonid Margolis;Robin Shattock

  • Cyanovirin-N Inhibits AIDS Virus Infections in Vaginal Transmission Models

    Che Chung Tsai;Peter Emau;Yonghou Jiang;Michael B. Agy

  • Blockade of Attachment and Fusion Receptors Inhibits HIV-1 Infection of Human Cervical Tissue

    Qinxue Hu;Ines Frank;Vennansha Williams;John J. Santos

  • Mycobacterial 65-kD heat shock protein induces release of proinflammatory cytokines from human monocytic cells.

    J. S. Friedland;R. Shattock;D. G. Remick;G. E. Griffin

  • Antiretroviral Drug–Based Microbicides to Prevent HIV-1 Sexual Transmission

    Per Johan Klasse;Robin Shattock;John P. Moore

  • Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9.

    Chang Li;Xinmeng Guan;Tao Du;Wei Jin

  • Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial

    Unknown

  • Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial.

    Sonya Abraham;Helene B Juel;Peter Bang;Hannah M Cheeseman

  • Biological and Technical Variables Affecting Immunoassay Recovery of Cytokines from Human Serum and Simulated Vaginal Fluid: A Multicenter Study

    Raina N. Fichorova;Nicola Richardson-Harman;Massimo Alfano;Laurent Belec

  • Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA.

    Anna K Blakney;Paul F McKay;Bárbara Ibarzo Yus;Yoann Aldon

  • Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.

    Martin Cranage;Sally Sharpe;Carolina Herrera;Alethea Cope

  • IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis.

    Asna A. Siddiqui;Annemarie E. Brouwer;Annemarie E. Brouwer;Vannaporn Wuthiekanun;Shabbar Jaffar

  • Emerging Technologies for Low-Cost, Rapid Vaccine Manufacture.

    Zoltán Kis;Robin Shattock;Nilay Shah;Cleo Kontoravdi

  • Selective transmission of R5 HIV-1 variants: where is the gatekeeper?

    Jean-Charles Grivel;Robin J Shattock;Leonid B Margolis

Frequent Co-Authors

George E. Griffin
George E. Griffin St George's, University of London
Jon S. Friedland
Jon S. Friedland St George's, University of London
John P. Moore
John P. Moore Cornell University
Leonid Margolis
Leonid Margolis National Institutes of Health
Gavin Andrews
Gavin Andrews University of New South Wales
Peter A. Anton
Peter A. Anton University of California, Los Angeles
Jean-Charles Grivel
Jean-Charles Grivel Sidra Medical and Research Center
Per Johan Klasse
Per Johan Klasse Cornell University
Thomas J. Hope
Thomas J. Hope Northwestern University
Sharon J. Peacock
Sharon J. Peacock University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, expanding their qualifications with related healthcare degrees can open diverse career opportunities. Many professionals pursue nursing pathways that complement immunological expertise, such as becoming a psychiatric nurse practitioner. Affordable PMHNP programs offer cost-effective routes to specialize in mental health, a sector closely linked to immune system studies.

Nurses holding a Doctor of Nursing Practice (DNP) degree can also benefit from understanding salary prospects by state, helping them make informed decisions about where to advance their careers. The data on doctorate in nursing salary highlights the potential financial rewards, motivating many to pursue advanced roles combining clinical and immunological knowledge.

Transitioning from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner (ACNP) is another valuable pathway. Online bridge programs, like the FNP to ACNP bridge program online, enable working nurses to acquire acute care skills without pausing their careers, aligning well with clinical immunology applications in acute and critical care settings.

For those seeking a quicker entry into nursing specialties, accelerated FNP programs provide intensive, streamlined education paths. These programs support faster transitions into family nursing roles that often intersect with primary immunological care and prevention.

Best Scientists Citing Robin J. Shattock

Trending Scientists